JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for BIOGEN INC. · Global biotechnology company

Filing 4th Quarter - Termination Amendment

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $50,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Medicare/Medicaid

Issues related to Medicare Part B and Part D

Health Issues

Issues related to the pharmaceutical industry

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.